| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 672588 | 72840 | BETAHISTINA QUALIGEN 8 mg COMPRIMIDOS EFG | BETAHISTINA QUALIGEN 8 mg COMPRIMIDOS EFG, 60 comprimidos | 8 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72840/72840_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72840/72840_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2010-10-14 | 1 | 1 | 1 | 2010-10-14 | 2010-10-14 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 672662 | 72841 | BETAHISTINA QUALIGEN 16 mg COMPRIMIDOS EFG | BETAHISTINA QUALIGEN 16 mg COMPRIMIDOS EFG, 30 comprimidos | 16 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72841/72841_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72841/72841_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2010-10-14 | 1 | 1 | 1 | 2010-10-14 | 2010-10-14 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 673779 | 73677 | OLANZAPINA FLAS QUALIGEN 5 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS QUALIGEN 5 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73677/73677_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73677/73677_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 673781 | 73678 | OLANZAPINA FLAS QUALIGEN 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS QUALIGEN 10 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73678/73678_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73678/73678_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 673782 | 73678 | OLANZAPINA FLAS QUALIGEN 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA FLAS QUALIGEN 10 mg COMPRIMIDOS BUCODISPERSABLES EFG, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73678/73678_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73678/73678_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 672370 | 72025 | DRETINELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 3 mg/0,02 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72025/72025_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72025/72025_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | THERAMEX HEALTHCARE SPAIN S.L. | 2010-07-07 | 1 | 1 | 1 | 2010-07-07 | 2010-08-09 | 1 | 2011-05-18 | View Edit Delete | ||||||||||||
| 672371 | 72027 | DRETINE 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINE 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 3 mg/0,03 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72027/72027_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72027/72027_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | THERAMEX HEALTHCARE SPAIN S.L. | 2010-07-07 | 1 | 1 | 1 | 2010-07-07 | 2010-08-09 | 1 | 2011-05-18 | View Edit Delete | ||||||||||||
| 672372 | 72035 | DRETINELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINELLE DIARIO 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 3 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72035/72035_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72035/72035_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | THERAMEX HEALTHCARE SPAIN S.L. | 2010-07-05 | 1 | 1 | 1 | 2010-07-05 | 2010-08-09 | 1 | 2011-05-18 | View Edit Delete | ||||||||||||
| 672373 | 72192 | DRETINE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DRETINE DIARIO 0.03 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 3 mg/0,03 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72192/72192_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72192/72192_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | THERAMEX HEALTHCARE SPAIN S.L. | 2010-07-05 | 1 | 1 | 1 | 2010-07-05 | 2010-08-09 | 1 | 2011-07-05 | View Edit Delete | ||||||||||||
| 672138 | 08482001 | AZARGA 10 MG/ML + 5 MG/ML COLIRIO EN SUSPENSION | AZARGA 10 MG/ML + 5 MG/ML COLIRIO EN SUSPENSION, 1 frasco de 5 ml | 10 mg/ml + 5 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08482001/08482001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08482001/08482001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2008-12-19 | 1 | 1 | 1 | 2008-12-19 | 2011-07-14 | 1 | 2011-10-17 | 661962 | View Edit Delete | |||||||||||
| 673090 | 24797 | HISTAVERIN 2 mg/ml JARABE | HISTAVERIN 2 mg/ml JARABE , 1 frasco de 250 ml | 10 mg/5 ml | 6 | 250 | 26 | 1 frasco de 250 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/24797/24797_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/24797/24797_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 953 | LABORATORIO ALDO UNION S.L. | 1955-11-01 | 1 | 1 | 1 | 1955-11-01 | 2011-07-13 | 1 | 2011-09-16 | 741223 | Lista III | View Edit Delete | ||||||||||
| 672418 | 72690 | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL, 1 frasco de 200 ml (vidrio) | 3,54 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml (vidrio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72690/72690_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72690/72690_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2010-09-02 | 1 | 1 | 1 | 2010-09-02 | 2010-09-02 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 672419 | 72690 | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL, 1 frasco de 120 ml (vidrio) | 3,54 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml (vidrio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72690/72690_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72690/72690_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2010-09-02 | 1 | 1 | 1 | 2010-09-02 | 2010-09-02 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 672975 | 49417 | SENIORAL JARABE NIÑOS | SENIORAL JARABE NIÑOS, 1 frasco de 150 ml | 2,25 mg/15 ml + 19,5 mg/15 ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49417/49417_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49417/49417_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1971-07-01 | 1 | 1 | 1 | 1971-07-01 | 2011-05-16 | 1 | 2011-09-09 | 699256 | View Edit Delete | |||||||||||
| 673046 | 61461 | NASOLINA 0,57 MG/ML SOLUCIÓN PARA PULVERIZACIÓN NASAL | NASOLINA 0,57 MG/ML SOLUCIÓN PARA PULVERIZACIÓN NASAL, 1 envase pulverizador de 20 ml | 0,5 mg/ml | 6 | 20 | 26 | 1 envase pulverizador de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61461/61461_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61461/61461_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 1997-03-01 | 1 | 1 | 1 | 1997-03-01 | 1997-05-01 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 673622 | 63916 | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 28 cápsulas | 20 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63916/63916_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63916/63916_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2001-05-22 | 1 | 1 | 1 | 2001-05-22 | 2011-03-16 | 1 | 2015-08-11 | View Edit Delete | ||||||||||||
| 673623 | 63916 | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TECNIGEN 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas | 20 mg | 6 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63916/63916_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63916/63916_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2001-05-22 | 1 | 1 | 1 | 2001-05-22 | 2011-03-16 | 1 | 2016-04-07 | View Edit Delete | ||||||||||||
| 672140 | 71101 | LATANOPROST TEVA-RATIOPHARM 50 microgramos/ml COLIRIO EN SOLUCION | LATANOPROST TEVA-RATIOPHARM 50 microgramos/ml COLIRIO EN SOLUCION, 1 frasco de 2,5 ml | 50 microgramos/ml | 6 | 2,5 | 26 | 1 frasco de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71101/71101_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71101/71101_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2010-02-09 | 1 | 1 | 1 | 2010-02-09 | 2011-03-09 | 1 | 2011-07-23 | 664794 | View Edit Delete | |||||||||||
| 672765 | 72989 | IBUDOL ROLL-ON 50 MG/G GEL ENVASE CON APLICADOR DE BOLA | IBUDOL ROLL-ON 50 MG/G GEL ENVASE CON APLICADOR DE BOLA , 1 tubo de 60 g | 50 mg/g | 6 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72989/72989_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72989/72989_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2010-11-11 | 1 | 1 | 1 | 2010-11-11 | 2010-11-11 | 1 | 2020-05-22 | View Edit Delete | ||||||||||||
| 674081 | 72752 | DORZOLAMIDA ARISTO 20 mg/ml COLIRIO EN SOLUCION | DORZOLAMIDA ARISTO 20 mg/ml COLIRIO EN SOLUCION , 1 frasco de 5 ml | 20 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72752/72752_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72752/72752_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 13469 | ARISTO PHARMA IBERIA S.L. | 2011-06-06 | 1 | 1 | 1 | 2011-06-06 | 2011-06-06 | 1 | 2019-01-18 | View Edit Delete |
Page 262 of 1036, showing 20 records out of 20704 total, starting on record 5221, ending on 5240